Regarding the Jan. 23 Kyodo article "U.S. won't breach 'mixed treatment' medical insurance rules in TPP talks": It would seem to me that the Japan Medical Association (JMA), which consists of mainly nonhospital physicians, should seek the opinion of citizens and hospitals before making pronouncements on mixed-treatment restrictions. The health ministry could easily control and approve a process for hospitals wishing to provide such treatments.
Many patients seeking access to cutting-edge and proven technologies not yet approved in Japan are denied options in which the cost is split between national insurance and out-of-pocket payments. The all-private payment or all insurance payment regulation (no commingling) is severely restricting patient choice.
Regardless of the discussions over the Trans-Pacific Partnership Agreement, if the JMA and health ministry are concerned about cash-strapped hospitals going under, perhaps advocating exemptions for hospitals from consumption tax increases and the planned 17 percent increase in electricity rates is a better strategy than blocking the latest medical advances except for the super-rich.
The opinions expressed in this letter to the editor are the writer's own and do not necessarily reflect the policies of The Japan Times.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.